Tresmares Capital has taken a minority stake in Rioja Nature Pharma
Madrid – CFI is pleased to announce that it acted as exclusive financial advisor to Rioja Nature Pharma in its sale of a minority stake to Tresmares Capital through a sharecapital increase.
Rioja Nature Pharma is a leading dietary supplements manufacturer for third parties with expected revenues of >€40M in 2023.
Tresmares Capital is a pan-European growth-focused alternative investment firm operating in Spain, the United Kingdom and Portugal. Founded in 2020 and comprising a team of 50 investment professionals, the firm offers an extensive range of financing solutions to both high-growth SMEs and their private equity backers.
This transaction closed in November 2023.
Food & Beverage & Agribusiness
has sold minority stake to
Transaction details
Leading dietary supplement provider Rioja Nature Pharma has sold a minority stake to private equity fund Tresmares Capital
This transaction was advised by:
Our latest transactions
Real Estate & Construction
have been acquired by
Transaction details
Flatiron Steel, Teton Steel, And Epic Steel have been acquired by Gibraltar Industries
Industrials
have been acquired by
Transaction details
The Grote Family of Brands have sold a minority interest to Brown Brothers Harriman Capital Partners Private Equity.
Transport & Logistics
has sold a majority stake to
Transaction details
ZABERD, Poland's leading provider of road and motorway maintenance services, has sold a majority stake to international construction company STRABAG
Business Services
has been acquired by
a subsidiary of
Transaction details
Reolon, a regional insurance brokerage firm focused on agribusiness, has been sold to Alper Seguros, a subsidiary of Warburg Pincus
